Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Pfizer Inc (PFE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
22nd Century Accepted to Present Proprietary Smoking Cessation Product at BIOCHINA Partnering Forum in Zhuhai, China

22nd Century Group, Inc. (NYSE MKT:XXII), a plant biotechnology company that is focused on tobacco harm reduction and cannabis research, announced today that James Vail, the Company's ...

AZN : 30.49 (+0.83%)
NVO : 37.08 (+1.48%)
XXII : 1.45 (-2.03%)
PFE : 33.76 (+0.06%)
Circle Pharma Announces Expansion of Series A Financing and Appointment of James C. Lu to Its Board

Circle Pharma, Inc. today announced that it has completed an expansion of its Series A financing, with new investors WI Harper Group, Elements Partners, LLC, Whitesun Healthcare Ventures...

GBT : 30.50 (-0.16%)
IRBT : 69.14 (-0.17%)
MPWR : 96.21 (+1.01%)
PFE : 33.76 (+0.06%)
VIA : 44.78 (+0.74%)
Pfizer (PFE) Crosses Pivot Point Resistance at $33.76

Pfizer (NYSE:PFE) has opened bullishly above the pivot of $33.61 today and has reached the first level of resistance at $33.76. Should the shares continue to rise, the resistance pivots of $33.87 and...

PFE : 33.76 (+0.06%)
Is Pain Ahead for Healthcare ETFs After Weak JNJ Q1?

Results from Johnson and Johnson could be a warning sign for other drug makers, which are scheduled to report this week and the next.

VHT : 138.60 (+0.57%)
JNJ : 123.43 (+0.44%)
MRK : 62.30 (+0.26%)
IYH : 156.99 (+0.51%)
FHLC : 35.99 (+0.53%)
ABBV : 65.10 (+0.68%)
AMG : 166.12 (-0.20%)
GILD : 67.12 (+1.31%)
SPY : 238.55 (+0.58%)
AMGN : 164.70 (+0.96%)
PFE : 33.76 (+0.06%)
BMY : 53.94 (+0.73%)
Pivotal Phase III Study Underscores Efficacy Of Zavicefta(TM) (ceftazidime-avibactam) For Treatment Of Hospital-Acquired Pneumonia, A Leading Cause Of Mortality In Hospitals

Positive results of the REPROVE(1) Study showed that patients diagnosed with hospital-acquired pneumonia (HAP), treated with Zavicefta, a novel combination antibiotic for the treatment of...

PFE : 33.76 (+0.06%)
Is Pain Ahead for Healthcare ETFs After Weak JNJ Q1?

Results from Johnson and Johnson could be a warning sign for other drug makers, which are scheduled to report this week and the next.

VHT : 138.60 (+0.57%)
JNJ : 123.43 (+0.44%)
MRK : 62.30 (+0.26%)
IYH : 156.99 (+0.51%)
FHLC : 35.99 (+0.53%)
ABBV : 65.10 (+0.68%)
AMG : 166.12 (-0.20%)
GILD : 67.12 (+1.31%)
SPY : 238.55 (+0.58%)
AMGN : 164.70 (+0.96%)
PFE : 33.76 (+0.06%)
BMY : 53.94 (+0.73%)
FDA approves 2nd near-copy of Remicade for immune disorders

Federal regulators on Friday approved another alternative version of Remicade, an expensive injected drug widely used for rheumatoid arthritis and other immune system disorders.

JNJ : 123.43 (+0.44%)
MRK : 62.30 (+0.26%)
PFE : 33.76 (+0.06%)
Pfizer Receives Positive CHMP Opinion for BESPONSA(R) (Inotuzumab Ozogamicin) for the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia

Pfizer Inc. (NYSE:PFE) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval...

PFE : 33.76 (+0.06%)
Pfizer Unveils ATLAS(R), An Interactive, User-Friendly Website That Provides Global Antibiotic Resistance Surveillance Data Across 60 Countries

--ATLAS Can Also Help Inform Global Health Strategies To Mitigate The Threat Of Antimicrobial Resistance (AMR)

PFE : 33.76 (+0.06%)
AbbVie's (ABBV) Cancer Candidate Fails in Phase III Studies

AbbVie Inc. announced disappointing top-line results from two phase III studies evaluating veliparib in combination with chemotherapy for treatment of patients with squamous non-small cell lung cancer...

AZN : 30.49 (+0.83%)
JNJ : 123.43 (+0.44%)
ABBV : 65.10 (+0.68%)
PFE : 33.76 (+0.06%)
Global Monoclonal Antibody Therapeutics Market: Emergence of New Products to Generate Growth Opportunities for Players

ALBANY, New York, April 20, 2017 /PRNewswire/ --

BAYRY : 118.7560 (+0.60%)
MRK : 62.30 (+0.26%)
NVS : 76.24 (+2.18%)
GSK : 41.48 (+0.88%)
PFE : 33.76 (+0.06%)
Global Monoclonal Antibody Therapeutics Market: Emergence of New Products to Generate Growth Opportunities for Players

The global market for Monoclonal Antibody Therapeutics is expected to witness a high level of competition in the next few years, thanks to the rising number of players entering the market, states a research...

BAYRY : 118.7560 (+0.60%)
MRK : 62.30 (+0.26%)
NVS : 76.24 (+2.18%)
GSK : 41.48 (+0.88%)
PFE : 33.76 (+0.06%)
Is J&J's Pharma Sales Slowdown a Warning for Other Players?

Johnson & Johnson (JNJ) reported mixed first-quarter 2017 earnings results on Tuesday.

JNJ : 123.43 (+0.44%)
MRK : 62.30 (+0.26%)
AMGN : 164.70 (+0.96%)
PFE : 33.76 (+0.06%)
SNY : 46.40 (+1.09%)
BMY : 53.94 (+0.73%)
Lackluster J&J Q1 Pushes Healthcare ETFs Down

Johnson & Johnson continued its long streak of earnings beat but lagged our revenue estimate again on sluggish drug sales.

XLV : 74.73 (+0.43%)
VHT : 138.60 (+0.57%)
JNJ : 123.43 (+0.44%)
IHE : 150.69 (+0.45%)
IYH : 156.99 (+0.51%)
FHLC : 35.99 (+0.53%)
PFE : 33.76 (+0.06%)
Why Is Pfizer (PFE) Up 8.7% Since the Last Earnings Report?

Pfizer (PFE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

PFE : 33.76 (+0.06%)
Lackluster J&J Q1 Pushes Healthcare ETFs Down

Johnson & Johnson continued its long streak of earnings beat but lagged our revenue estimate again on sluggish drug sales.

XLV : 74.73 (+0.43%)
VHT : 138.60 (+0.57%)
JNJ : 123.43 (+0.44%)
IHE : 150.69 (+0.45%)
IYH : 156.99 (+0.51%)
FHLC : 35.99 (+0.53%)
PFE : 33.76 (+0.06%)
Roche's (RHHBY) Cancer Drug Gets FDA Nod for Label Expansion

Roche Holding AG's (RHHBY) unit, Genentech, announced that its drug Tecentriq (atezolizumab) has received FDA approval on an accelerated basis for initial treatment of people with advanced urothelial carcinoma...

MRK : 62.30 (+0.26%)
RHHBY : 32.4070 (+1.24%)
PFE : 33.76 (+0.06%)
BMY : 53.94 (+0.73%)
J&J (JNJ) Q1 Earnings Beat Estimates, Pharma Sales Slow Down

Johnson & Johnson (JNJ) reported mixed first quarter results, with earnings beating expectations while sales missing the same.

ALIOF : 280.5000 (-0.18%)
JNJ : 123.43 (+0.44%)
MRK : 62.30 (+0.26%)
PFE : 33.76 (+0.06%)
Did Pharma & Biotech M&As Pick Pace in Q1?

Post-election, hopes surged that there would be an increase in M&A activity in the pharma and biotech sector in 2017.

JNJ : 123.43 (+0.44%)
AGN : 238.22 (+0.52%)
SHPG : 176.68 (+0.55%)
GILD : 67.12 (+1.31%)
TEVA : 30.76 (-2.66%)
PFE : 33.76 (+0.06%)
SNY : 46.40 (+1.09%)
5 Stocks to Watch as Canada Gets Hooked on Cannabis

No bull market has grown bigger horns this decade than medical marijuana, and while there's not as much big pot money to get in on in the U.S., the Canadian play ground is about to explode. Big pharma...

GUD.TO : 10.37 (-0.10%)
MRK : 62.30 (+0.26%)
JNJ : 123.43 (+0.44%)
NVS : 76.24 (+2.18%)
PFE : 33.76 (+0.06%)
SNY : 46.40 (+1.09%)

Van Meerten Stock Picks

Mall REIT Caution
I believe in the Efficient Market Theory -- in the long run.
GGP +0.06 , DDR +0.18 , REG -0.08 , SPG -0.90 , CBL -0.05 , KIM +0.13 , MAC +0.02 , WPG -0.07 , WRI -0.53
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Barchart Morning Call

OVERNIGHT MARKETS AND NEWS Jun E-mini S&Ps ( ESM17 +0.17%) this morning are up +0.17% and European stocks are up +0.19% at a 20-month high on positive carry-over from Sunday's presidential elections in France. The results of the election have... Read More

Chart of the Day

Beasley Broadcast Group (BBGI) is the Barchart Chart of the Day.  The radio stations owner operator has a Trend S[potter buy signal, a Weighted Alpha of 399.43+ and gained 340.70% in the last year.
Read More

Brugler Ag Report

Today's Commentary

Corn futures closed the day 4 to 6 1/4 cents higher on Tuesday. Moisture is expected in most of the Corn Belt this week, which is likely to be heavy enough to slow planting progress. The weekly EIA report will be released tomorrow morning at 9:30 a.m...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.